Purchase Order 75N92019P00365
Award Date 8/30/19
Potential Completion Date 9/30/19
Potential Value $432K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The University of Washington was awarded a firm fixed-price purchase order in the amount of thirteen thousand one hundred sixty-nine dollars and twenty-six cents ($13,169.26) by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for platelet RNA sequencing services in support of the Framingham Heart Study, with no set-aside designation. Performance will take place in Bethesda, Maryland through September 2020. No...
- The University of Washington, doing business as the Northwest Genomics Center, has been awarded a firm fixed price purchase order valued at seventy-two thousand nine hundred sixty-six dollars and fifteen cents ($72,966.15) by the National Heart, Lung and Blood Institute of the National Institutes of Health. Under this contract, the Center will perform high-throughput sequencing of RNAs in three hundred platelet cell samples to support the Institute's research efforts. The work will be...
- This federal contract award to the University of Washington (UW) was issued by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), for RNA sequencing laboratory services. The $429,539.93 firm-fixed-price contract has an ultimate completion date of October 17, 2020. UW will provide the required RNA sequencing and data analysis services on biological samples to further NHLBI's scientific research. This award is not associated with a...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to University of Washington for $17,027.00 on September 30, 2017, for research identifying commensuration bias in NIH/CSR peer review. Work is performed at the university's Office of Sponsored Programs in Bethesda, Maryland. The purchase order carries a firm fixed price structure. Ultimate completion is scheduled for April 27, 2018.</p>
- <p>The National Heart Lung and Blood Institute issued a purchase order to New York University School of Medicine valued at $11,864.00, awarded on March 7, 2018, with ultimate completion on March 14, 2019. The order is a firm fixed-price acquisition with no set-aside. Performance takes place in New York, NY. The source does not specify the goods or services procured.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Medstar Health Research Institute Inc. for $23,925.00 on November 10, 2020, to process samples for NIH/Medstar Health Baltimore cell-free DNA COVID-19 research over an estimated one-year period. Performance occurs at University Park, Maryland. The order funds laboratory sample processing services in support of pulmonary function research conducted by Sean Agbor-Enoh and NHLBI pulmonary function lab staff, under firm...
- This is a prime federal contract award from the National Heart Lung and Blood Institute, a subcomponent of the Department of Health and Human Services, to the University of Washington (UW). The $11,349,244.46 cost-plus-award-fee contract is for the Laboratory Centers for DNA Re-sequencing & Genotyping Program, which provides specialized research and laboratory services. The contract is not set aside for small businesses. UW is a large public research university that frequently secures...
- <p>The National Heart Lung and Blood Institute issued a $61,208.46 delivery order to Illumina, Inc. on September 14, 2015, for genetic sequencing and genomic analysis equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order carried a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. valued at $190,561.89 on June 5, 2018, with final completion on June 4, 2019. The order is firm fixed-price with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order covers Illumina service contract requirements, typical of the vendor's federal work providing genetic sequencing systems, reagents, and bioinformatics support to research institutions across civilian agencies.
- <p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for $79,200 on February 27, 2018, for CLIA-approved genetic sequencing services, with final completion on February 26, 2019. Work is performed in Chicago, Illinois. Pricing is firm fixed price with no small business set-aside.</p>
The National Heart Lung and Blood Institute awarded a purchase order to University of Washington for $432,005.00 on August 30, 2019 for RNA sequencing of Framgiovanni Heart Study samples, with a firm fixed price and completion date of September 30, 2019. Place of performance is Bethesda, Maryland. No set-aside was used.
Generated 6/1/26, 10:56 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $432.0k | 8/29/19 |